Andy Pasternak - Dec 30, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP, Chief Strategy Officer
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Dec 30, 2022
Transactions value $
-$4,473,819
Form type
4
Date filed
1/4/2023, 03:14 PM
Previous filing
Dec 29, 2022
Next filing
Jan 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +88.7K +260.62% 123K Dec 30, 2022 Direct F1
transaction HZNP Ordinary Shares Tax liability -$4.47M -39.3K -32.02% $113.80 83.5K Dec 30, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Performance Restricted Stock Units (PSU) Options Exercise $0 -8.71K -100% $0.00* 0 Dec 30, 2022 Ordinary Shares 8.71K Direct F1, F2
transaction HZNP Performance Restricted Stock Units (PSU) Options Exercise $0 -2.36K -100% $0.00* 0 Dec 30, 2022 Ordinary Shares 2.36K Direct F1, F2
transaction HZNP Performance Restricted Stock Units (PSU) Options Exercise $0 -5.8K -100% $0.00* 0 Dec 30, 2022 Ordinary Shares 5.8K Direct F1, F2
transaction HZNP Performance Restricted Stock Units (PSU) Options Exercise $0 -26.1K -100% $0.00* 0 Dec 30, 2022 Ordinary Shares 26.1K Direct F1, F2
transaction HZNP Performance Restricted Stock Units (PSU) Options Exercise $0 -11.6K -66.7% $0.00 5.82K Dec 30, 2022 Ordinary Shares 11.6K Direct F1, F3
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -14.5K -100% $0.00* 0 Dec 30, 2022 Ordinary Shares 14.5K Direct F1, F2
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -11.6K -50% $0.00 11.6K Dec 30, 2022 Ordinary Shares 11.6K Direct F1, F3
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -7.94K -33.33% $0.00 15.9K Dec 30, 2022 Ordinary Shares 7.94K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer.
F2 The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022.
F3 The remaining ordinary shares subject to the PSU/RSU vest on January 5, 2024.
F4 The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025.